Comparative efficacy of two primary care interventions to assist withdrawal from long term benzodiazepine use: A protocol for a clustered, randomized clinical trial
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Although benzodiazepines are effective, long-term use is not recommended because of potential adverse effects; the risks of tolerance and dependence; and an increased risk of hip fractures, motor vehicle accidents, and memory impairment. The estimated prevalence of long-term benzodiazepine use in the general population is about 2,2 to 2,6%, is higher in women and increases steadily with age. Interventions performed by General Practitioners may help patients to discontinue long-term benzodiazepine use. We have designed a trial to evaluate the effectiveness and safety of two brief general practitioner-provided interventions, based on gradual dose reduction, and will compare the effectiveness of these interventions with that of routine clinical practice. METHODS/DESIGN: In a three-arm cluster randomized controlled trial, general practitioners will be randomly allocated to: a) a group in which the first patient visit will feature a structured interview, followed by visits every 2-3 weeks to the end of dose reduction; b) a group in which the first patient visit will feature a structured interview plus delivery of written instructions to self-reduce benzodiazepine dose, or c) routine care. Using a computerized pharmaceutical prescription database, 495 patients, aged 18-80 years, taking benzodiazepine for at least 6 months, will be recruited in primary care health districts of three regions of Spain (the Balearic Islands, Catalonia, and Valencia). The primary outcome will be benzodiazepine use at 12 months. The secondary outcomes will include measurements of anxiety and depression symptoms, benzodiazepine dependence, quality of sleep, and alcohol consumption. DISCUSSION: Although some interventions have been shown to be effective in reducing benzodiazepine consumption by long-term users, the clinical relevance of such interventions is limited by their complexity. This randomized trial will compare the effectiveness and safety of two complex stepped care interventions with that of routine care in a study with sufficient statistical power to detect clinically relevant differences. TRIAL REGISTRATION: Current Controlled Trials: ISRCTN13024375.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Brief interventions 477 have included sending a letter to patients who are long-term benzodiazepine users suggesting they stop, [16][17][18][19] resulting in discontinuation rates between 10% and 24% at 6-month follow-up”
From Comparative efficacy of two interventions to discontinue long-term benzodiazepine use: cluster randomised controlled trial in primary care (2014) · cites this paper as [17]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings
Denis, C., Fatseas, M., Lavie, E., & Auriacombe, M. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005194.pub2 · Cited by 122 · cited 1×
“Addition of either psychological interventions [27-29] or substitutive pharmacotherapy [30] to gradual BZD dose reduction has also been evaluated.”
BackgroundRetractedThe Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits
Glass, J., Lanctôt, K. L., Herrmann, N., Sproule, B. A., & Busto, U. E. (2005) · BMJ · doi:10.1136/bmj.38623.768588.47 · Cited by 1,161 · cited 1×
“A meta-analysis evaluating the risks and benefits of longterm BZD use to treat insomnia in adults aged > 60 years concluded that, although sleep quality improved, the magnitude of the effect was small and drug use exposed patients to an increased risk of adverse effects [10].”
BackgroundQuintana, J. M., Padierna, A., Esteban, C., Arostegui, I., Bilbao, A., & Ruiz, I. (2003) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2003.00062.x · Cited by 428 · cited 1×
“Secondary outcome measures The occurrence of symptoms of anxiety and depression will be assessed at 0, 6, and 12 months using the Hospital Anxiety and Depression (HAD) scale [31,32].”
MethodMorin, C. M., Bastien, C., Guay, B., Radouco-Thomas, M., Leblanc, J., & Vallières, A. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.2.332 · Cited by 348 · cited 1×
“Addition of either psychological interventions [ 27-29 ] or substitutive pharmacotherapy [30] to gradual BZD dose reduction has also been evaluated.”
BackgroundHerings, R. M. C. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.16.1801 · Cited by 331 · cited 1×
“Prolonged use of BZDs may produce somnolence, memory impairment, and daytime drowsiness; may cause falls resulting in hip fractures; and may result in motor vehicle accidents [7-9].”
BackgroundWang, P. S., Bohn, R. L., Glynn, R. J., Mogun, H., & Avorn, J. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.6.892 · Cited by 312
Sample Size Calculations for Cluster Randomised Trials
Campbell, M., Grimshaw, J., Steen, N., & Changing Professional Practice in Europe Group (EU BIOMED II Concerted Action) (2000) · Journal of Health Services Research & Policy · doi:10.1177/135581960000500105 · Cited by 298
Effectiveness of current treatment approaches for benzodiazepine discontinuation: a meta‐analysis
Parr, J. M., Kavanagh, D. J., Cahill, L., Mitchell, G., & Young, R. M. (2009) · Addiction · doi:10.1111/j.1360-0443.2008.02364.x · Cited by 212
Strategies for discontinuing long-term benzodiazepine use: Meta-analysis
Voshaar, R. C. O., Couvée, J. E., Van Balkom, A. J. L. M., Mulder, P. G. H., & Zitman, F. G. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.189.3.213 · Cited by 205
Research works printed but not linked: 4
- Encuesta Nacional de Salud de España 2006 monografía en Internet 2008 Madrid: Ministerio de Sanidad y Consumo http://www.msc.es/estadEstudios/estadisticas/encuestaNacional/encuestaNac2006/UtilizacionServiciosSanitariosAbsoluto.xls accessed 2nd February 2011
- Ministerio de Sanidad y Consumo (MSC) Guía de Prescripción Terapéutica (GPT) Adaptación española de la 51°ed. del British National Formulary (BNF) 1°ed. Española 2006 Barcelona: Pharma Editores S.L
- National Collaborating Centre for Mental Health Depression. The treatment and management of depression in adults 2009 London (UK): National Institute for Health and Clinical Excellence (NICE) 64 Clinical guideline; no. 90
- National Collaborating Centre for Mental Health Anxiety: management of anxiety (panic disorder, with or without agoraphobia, and generalised anxiety disorder) in adults in primary, secondary and community care 2004 London (UK): National Institute for Health and Clinical Excellence (NICE) 88 Clinical guideline; no. 22 20945576
Cited by
Vicens, C., Bejarano, F., Sempere, E., Mateu, C., Fiol, F., Socias, I., Aragonès, E., Palop, V., Beltran, J. L., Piñol, J. L., et al. (2014) · British Journal of Psychiatry · doi:10.1192/bjp.bp.113.134650 · Cited by 122
Self-citationThe Problems of Long-Term Treatment With Benzodiazepines and Related Substances
Janhsen, K., Roser, P., & Hoffmann, K. (2015) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2015.0001 · Cited by 114
Vicens, C., Sempere, E., Bejarano‐Romero, F., Socias, I. M., Mateu, C., Fiol, F., Palop, V., Mengual, M., Folch, S., Calatayud, G. L., et al. (2016) · British Journal of General Practice · doi:10.3399/bjgp16x683485 · Cited by 58
Self-citationFeasibility of discontinuing chronic benzodiazepine use in nursing home residents: a pilot study
Bourgeois, J., Elseviers, M. M., Bortel, L. M. V., Petrović, M., & Stichele, R. V. (2014) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-014-1725-7 · Cited by 44
“Others focused on the discontinuation process [48, 49].”
Psychiatric emergencies (part II): psychiatric disorders coexisting with organic diseases.
Testa, A. C., Giannuzzi, R., Sollazzo, F., Petrongolo, L., Bernardini, L., & Dain, S. (2013) · PubMed · Cited by 40
Metadata
- Authors
- Vicens, C., Socias, I., Mateu, C., Leiva, A., Bejarano, F., Sempere, E., Basora, J., Palop, V., Mengual, M., Beltran, J. L., Aragonès, E., Lera, G., Folch, S., Piñol, J. L., Esteva, M., Roca, M., Arenas, A., del Mar Sureda, M., Campoamor, F., & Fiol, F.
- Affiliations
- Servei de Salut de les Illes Balears (ES)
- Generalitat Valenciana (ES)
- Instituto de Salud Carlos III (ES)
- Conselleria de Sanitat Universal i Salut Pública (ES)
- Hospital Universitario Son Espases (ES)
- Corresponding author
- Vicens, Caterina
- ORCID
- Venue
- BMC Family Practice
- Published
- 2011-04-20
- Volume
- 12
- Issue
- 1
- Pages
- 23-23
- ISSN
- 1471-2296 (ISSN-L)
- PMC
- PMC3105938
- OpenAlex
- W2163820542
- Cited by
- 26
- References
- 28
- Citations by year
- 2024: 1 · 2022: 3 · 2021: 1 · 2019: 4 · 2018: 1 · 2017: 1 · 2016: 4 · 2015: 2 · 2014: 4 · 2013: 3 · 2012: 2
- FWCI
- 1.37
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/2.0 (tdm)
- Locations
- BMC Family Practice (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Hispana (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Docusalut (Conselleria de Salut i Consum del Govern de les Illes Balears) (submittedVersion, cc-by)
- Funders
- Instituto de Salud Carlos III
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- benzodiazepine withdrawal, long-term benzodiazepine use, gradual dose reduction, stepped care, primary care, benzodiazepine dependence, anxiety symptoms, depressive symptoms, sleep quality, alcohol consumption
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Anxiety, Benzodiazepines, Depression, Humans, Interviews as Topic, Middle Aged, Patient Education as Topic, Primary Health Care, Research Design, Substance Withdrawal Syndrome, Single-Blind Method, Substance-Related Disorders, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comparative efficacy of two primary care interventions to assist withdrawal from long term benzodiazepine use: A protocol for a clustered, randomized clinical trial. https://app.cochat.ai/papers/10.1186/1471-2296-12-23
- The paper
- Vicens, C., Socias, I., Mateu, C., Leiva, A., Bejarano, F., Sempere, E., Basora, J., Palop, V., Mengual, M., Beltran, J. L., Aragonès, E., Lera, G., Folch, S., Piñol, J. L., Esteva, M., Roca, M., Arenas, A., del Mar Sureda, M., Campoamor, F., & Fiol, F. (2011). Comparative efficacy of two primary care interventions to assist withdrawal from long term benzodiazepine use: A protocol for a clustered, randomized clinical trial. BMC Family Practice. https://doi.org/10.1186/1471-2296-12-23
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
